Filtered By:
Specialty: Pharmaceuticals
This page shows you your search results in order of date. This is page number 5.
Order by Relevance | Date
Total 6905 results found since Jan 2013.
WHO Declares COVID-19 Global Emergency Over
FRIDAY, May 5, 2023 -- More than three years after the coronavirus began ravaging the planet, the World Health Organization announced Friday that the pandemic is no longer a public emergency. " It ' s with great hope that I declare COVID-19 over as a...
Source: Drugs.com - Pharma News - May 5, 2023 Category: Pharmaceuticals Source Type: news
Bell Palsy Incidence Higher With SARS-CoV-2 Infection Than Vaccine
TUESDAY, May 2, 2023 -- Incidence of Bell palsy is significantly more common following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection than after receipt of SARS-CoV-2 vaccinations, according to a review published online April...
Source: Drugs.com - Pharma News - May 2, 2023 Category: Pharmaceuticals Source Type: news
GSK sales fall after demand for Covid treatment plummets
US regulators say drugmaker’s Xevudy fails to tackle most prevalent variants of coronavirus
Source: FT.com - Drugs and Healthcare - April 26, 2023 Category: Pharmaceuticals Source Type: news
SARS-CoV-2 Infection Linked to Increased Risk for Diabetes
TUESDAY, April 18, 2023 -- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with an increased risk for diabetes, according to a study published online April 18 in JAMA Network Open.
Zaeema Naveed, M.B.B.S., Ph.D.,...
Source: Drugs.com - Pharma News - April 18, 2023 Category: Pharmaceuticals Source Type: news
What they are saying: Experts reinforce that TRIPS waiver expansion is harmful and unnecessary
At the direction of the U.S. Trade Representative, the U.S. International Trade Commission (USTIC) is investigating the impact of a proposed waiver of intellectual property (IP) protections for COVID-19diagnostics and therapeutics under the World Trade Organization Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS). Public submissions to the USITC from experts across patient groups, academia, public health, labor and the private sector make clear that, much like the original TRIPS waiver for COVID-19 vaccines, the proposed expansion of the waiver to diagnostics and therapeutics is harmful and unnecessary.
Source: The Catalyst - April 13, 2023 Category: Pharmaceuticals Authors: Megan Van Etten Tags: Intellectual Property Vaccines Coronavirus TRIPS Waiver Source Type: news
Ursodeoxycholic Acid Cuts SARS-CoV-2 Infection, Severity
MONDAY, April 10, 2023 -- Ursodeoxycholic acid (UDCA) is associated with a reduction in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and COVID-19 severity in patients with cirrhosis, according to a study published online...
Source: Drugs.com - Pharma News - April 10, 2023 Category: Pharmaceuticals Source Type: news
David Crosby Died While Battling Covid-19, Per Graham Nash
According to Nash, Crosby had contracted the Covid-19 coronavirus a second time.
Source: Forbes.com Healthcare News - April 9, 2023 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Business /business Hollywood & Entertainment /hollywood-entertainment pharma standard Source Type: news
You Can Get Covid-19 From Coronavirus-Contaminated Surfaces, New Study Confirms
A study published The Lancet Microbe provides further support for regularly cleaning and disinfecting high-touch surfaces.
Source: Forbes.com Healthcare News - April 8, 2023 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science business pharma standard Source Type: news
We should learn from rival attempts to write pandemic history
Data-sharing was messy, as shown by duelling claims about who published the coronavirus genome sequence first
Source: FT.com - Drugs and Healthcare - April 5, 2023 Category: Pharmaceuticals Source Type: news
PhRMA provides comments and testimony to USITC investigation on COVID-19 medicines and the TRIPS Agreement
At the request of the U.S. Trade Representative, the U.S. International Trade Commission (USITC) is conducting aninvestigation and will issue an accompanying report concerning theTRIPS Agreement and a variety of issues related to COVID-19 diagnostics and therapeutics. According to USTR, the USITC report will inform future discussions within the United States and at the World Trade Organization (WTO) concerningpotential TRIPS waiver expansion.
Source: The Catalyst - March 30, 2023 Category: Pharmaceuticals Authors: Kevin Haninger Tags: Intellectual Property Vaccines Coronavirus TRIPS Waiver Source Type: news
InnovationRx: Amazon Takes On Healthcare Worker Burnout
InnovationRx is your weekly digest of healthcare news. Sign up!
Source: Forbes.com Healthcare News - March 29, 2023 Category: Pharmaceuticals Authors: Alex Knapp, Forbes Staff Tags: Healthcare /healthcare Innovation /innovation Science /science Venture Capital /venture-capital Editors' Pick editors-pick Newsletter No Paywall no-paywall Coronavirus Source Type: news
Risk for GI Disorders Increased After Acute Phase of COVID-19
MONDAY, March 27, 2023 -- People with severe acute respiratory syndrome coronavirus 2 infection have an increased risk for gastrointestinal disorders after the acute phase of COVID-19, according to a study published online March 7 in Nature...
Source: Drugs.com - Pharma News - March 27, 2023 Category: Pharmaceuticals Source Type: news
Celebrating the success of the COVID-19 vaccines, and looking to the future
It ’s been over three years since I saw my first COVID-19 patient in the emergency department. The image of that x-ray is burned into my memory: clusters of white spots spread out across both sides of the patient’s lung. A dramatic, and not all that common, clinical finding. The patient in front of me already had a fever and was breathing quickly, in need of extra oxygen support. I didn't know then the significance that patient would have on me, but three years later I think about them often, and how they marked the start of a three plus year journey that changed the world.
Source: The Catalyst - March 27, 2023 Category: Pharmaceuticals Authors: Michael Ybarra Tags: Research and Development Vaccines Coronavirus Government Price Setting Source Type: news
A nasal spray protects against coronavirus infection - Effective also against recent immune-evasive variants
Researchers have developed a molecule that is, when administered nasally, extremely effective in preventing the disease caused by all known variants of the SARS-CoV-2 virus. The molecule can be a key tool in preparing for future pandemics, as it is aimed at preventing both the transmission and spread of the virus.
In laboratory animal studies, a molecule known as TriSb92, developed by researchers at the University of Helsinki, has been confirmed as affording effective protection against coronavirus infection.
Source: World Pharma News - March 24, 2023 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
InnovationRx: Beethoven ’s Genome; Plus, Billionaires Back New Kind Of Health Research
InnovationRx is your weekly digest of healthcare news. Sign up!
Source: Forbes.com Healthcare News - March 22, 2023 Category: Pharmaceuticals Authors: Katie Jennings, Forbes Staff Tags: Science /science Innovation /innovation Healthcare /healthcare Editors' Pick editors-pick Newsletter No Paywall no-paywall Coronavirus technology alexknappblog Source Type: news
